Abstract
No public abstract is available from the verified source records.
Tzung‐Dau Wang, Yen‐Ho Wang, Tien‐Shang Huang, Ta‐Chen Su, Shin‐Liang Pan, Ssu‐Yuan Chen
Abstract
Authors
Institutions
Provenance
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Cardiovascular alterations after spinal cord injury: an overview
10.2174/1568016043477242 · 2004
Mortality, morbidity, and psychosocial outcomes of persons spinal cord injured more than 20 years ago
10.1038/sc.1992.124 · 1992
Tomographic thallium-201 myocardial perfusion imaging after intravenous dipyridamole in asymptomatic subjects with quad-riplegia
10.1016/0003-9993(93)90036-a · 1993
Cardiac stress testing with thallium-201 imaging reveals silent ischemia in individuals with paraplegia
10.1016/0003-9993(94)90669-6 · 1994
Inflammatory bio-markers in acute coronary syndromes: part II: acute-phase reactants and biomarkers of endothelial cell activation
10.1161/circulationaha.105.595538 · 2006
Inflammation in atherosclerosis
10.1038/nature01323 · 2002
New markers of inflammation and endothelial cell activation: Part I
10.1161/01.cir.0000089190.95415.9f · 2003
Fitness, inflammation, and the metabolic syndrome in men with paraplegia
10.1016/j.apmr.2004.11.020 · 2005
Inflammatory C-reactive protein and cytokine levels in asymptomatic people with chronic spinal cord injury
10.1016/j.apmr.2004.02.009 · 2005
crossref
Confidence 100%
pubmed
Confidence 98%
openalex
Confidence 95%
unpaywall
Confidence 95%
datacite
Confidence 0%
Circulating levels of IL-2R, ICAM-1, and IL-6 in spinal cord injuries
10.1016/s0003-9993(97)90008-3 · 1997
Serial concentrations of C-reactive protein as an indicator of urinary tract infection in patients with spinal injury
10.1136/jcp.39.8.851 · 1986
CDC/AHA workshop on markers of inflammation and cardiovascular disease
10.1161/01.cir.0000148980.87579.5e · 2004
International standards for neurological and functional classification of spinal cord injury. American Spinal Injury Association
10.1038/sj.sc.3100432 · 1997
Efficacy of cholesterol levels and ratios in predicting future coronary heart disease in a Chinese population
10.1016/s0002-9149(01)01843-4 · 2001
Relation of improvement in endothelium-dependent flow-mediated vasodilation after rosiglitazone to changes in asymmetric dimethylargi-nine, endothelin-1, and C-reactive protein in nondiabetic patients with the metabolic syndrome
10.1016/j.amjcard.2006.05.027 · 2006
Decline in muscle mass with age in women: a longitudinal study using an indirect measure
10.1053/meta.2002.33355 · 2002
Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
10.1016/s0140-6736(96)07591-5 · 1997
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
10.1056/nejm199704033361401 · 1997
Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease
10.1016/j.amjcard.2004.08.093 · 2005
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study
10.1161/01.cir.0000136588.62638.5e · 2004
Chronic sub-clinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)
10.1161/01.cir.102.1.42 · 2000
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study
10.1152/japplphysiol.00729.2002 · 2003
High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome
10.1016/j.metabol.2006.03.011 · 2006
Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris
10.1016/j.amjcard.2006.01.029 · 2006
Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury
10.1053/mr.2000.3848 · 2000
Endothelin: beyond a vasoconstrictor
10.1161/circulationaha.105.609271 · 2006
A novel potent vasoconstrictor peptide produced by endothelial cells
10.1038/332411a0 · 1988
Relationship between endothelin-1 concentration and metabolic alterations typical of the insulin resistance syndrome
10.1053/meta.2000.6257 · 2000
Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans
10.1530/eje.0.1500195 · 2004
Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis
10.1016/j.ijcard.2003.07.014 · 2004
Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population
10.1038/sj.ijo.0803264 · 2006
ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats
10.1161/01.hyp.0000117296.30296.14 · 2004
Inflammatory markers and the metabolic syndrome: insights from therapeutic interventions
10.1016/j.jacc.2005.06.082 · 2005
No additional external references are available.